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Ribosome inactivating proteins from Mirabilis jalapa L. (RIP MJ) has 
shown higher cytotoxic activity when being formulated as a nanoparticle. 
However, the selectivity of the delivery system is also an important aspect 
when it comes to cytotoxic cell therapy. Epithelial cell adhesion molecule 
(EpCAM) is a monomeric glycoprotein which is overexpressed in epithelial 
cancer cells. This study aim was to develop a model of targeted protein 
delivery system by formulating the base fraction of RIP MJ (RIP MJ-30) into 
alginate nanoparticles and conjugating it with anti-EpCAM antibody. RIP MJ-
30 was formulated in to nanoparticle using alginate and CaCl2 as cross-
linker. Optimization of conjugation reaction condition was done in the pH 
variation of 4.5, 5.5, and 6.5. The success of conjugation was analyzed 
qualitatively using native polyacrylamide gel electrophoresis (native-PAGE) 
method and BCA assay. The optimum formula of RIP MJ-30 nanoparticles 
was produced using 0.3% alginate and 0.2% CaCl2. Results indicated that 
optimum conjugation reaction was carried out at pH level of 5.5. The 
optimum native-PAGE condition was by using 8% polyacrylamide gel in 
duration of 6h. Characterization of nanoparticle resulted in particle size of 
205.0nm, zeta potential of -6.9mV, entrapment efficiency of 71.11±4.84%, 
and conjugation efficiency of 89.55±6.18%. It was concluded that RIP MJ-30 
was successfully formulated into alginate nanoparticle and conjugated to 
anti-EpCAM antibody through carbodiimide reaction using 1-ethyl-
(dimethylprophilamine) carbodiimide (EDAC).   





Ribosome Inactivating Proteins (RIP) are 
proteins that usually found in plants, and have the 
ability to irreversibly disturb protein synthesis 
process. This process happened by ribosome 
inactivation through specific mechanism known as 
site-specific rRNA N-glikosidase activity (Barbieri 
et al., 1993; Stirpe et al., 2006). Mirabilis jalapa, 
locally known as ‘four o’clock plant’ in Indonesia, 
have been found to contain RIPs with anti-cancer 
properties (Sismindari et al., 2010). Ikawati et al. 
(2006) has isolated RIP-like protein with 
molecular weight of 30 kDa from M. jalapa L. 
leaves, called MJ-30, which was toxic against              
T47D and SiHa cells (Ikawati et al., 2006). 
However, the use of proteins as a therapeutic 
agent is limited by its instability, non-selectivity, 
and rapid elimination by enzymatic degradation 
(Torchilin and Lukyanov, 2003). One potential 
strategy to overcome this challenge is                  
through targeted nanoparticle formulation of the 
protein using biopolymer, and followed by 
conjugation of antibody as a cancer cell targeting 
molecule.  
 
Targeted nanoparticle delivery system 
could be made by conjugation reaction to link the 
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particle surface onto a targeting molecule, with the 
ability to facilitate specific delivery to the targeted 
cells. Nanoparticles conjugated onto monoclonal 
antibody is an option for cancer therapy (Scott et 
al., 2012). Previous studies have shown that 
nanoparticles of RIP MJ formulated with various 
polymers have higher cytotoxic effect compared to 
unformulated RIP MJ (Feranisa et al., 2015). 
Epithelial Cell Adhesion Molecule (EpCAM) which 
is overexpressed in epithelial cancer cells, is a 
potential target molecule for targeted protein 
therapy for epithelial cancer. Conjugation of               
anti-EpCAM antibody onto RIP MJ nanoparticle 
have been done previously but shown only a   
small increase of cytotoxic effects of the protein 
towards T47D cells due to non-optimal 
conjugation process (Witjaksono et al., 2016). 
Further study on the use of combination of 
chitosan and pectin as constituent, resulting in RIP 
MJ-anti-EpCAM nanoparticles with better 
entrapment efficiency but bigger diameter size 
(Pertiwi et al., 2018).  In this study we used 
alginate as the biopolymer having negatively 
charged groups, that would  work well to create 
poly-electrolytes complex based-nanoparticle with 
the positively charged RIP MJ-30. The use of 
calcium chloride as cross linker is aimed to form 
RIP MJ 30-anti-EpCAM nanoparticles with desired 
diameter size. 
The conjugation reaction between alginate 
nanoparticles with anti EpCAM antibody                       
was facilitated by EDAC (1-ethyl-
(dimethylprophilamine)carbodiimide). EDAC is a 
catalyst to facilitate the formation of amide                
bond between amine and carboxylate functional 
groups (Hermanson, 1996). Alginate has an 
abundance of carboxylate groups that could be 
activated by EDAC to react with the amine               
groups of the antibody. The reactivity of of both 
amine and carboxylate groups are known to be 
affected by the environment pH. Hence, the 
objective of this study is to obtain the                   
optimal medium pH for the EDAC-catalyzed 
conjugation process. Analysis for protein-bound 
particle was done by Native/non-denaturing 
Polyacrylamide Gel Electro-phoresis (Native 
PAGE). Native-PAGE is a gel electrophoresis 
method which is generally used for separations             
of proteins which native form wanted to be 
preserved because in Native-PAGE (Wittig and 
Schägger, 2005). Therefore, the success of                   
bio-conjugation of RIP-MJC nanoparticle with            
the targeting protein might be able to detect by 
native-PAGE.  
MATERIAL AND METHODS 
Formulation of RIP MJ-30 nanoparticle using 
Alginate and CaCl2 
Formulation of RIP MJ-30 nanoparticle was 
conducted based on Saraei et al. (2013) (Saraei et 
al., 2013). Six hundred µL of RIP-MJ-30 solution               
in TRIS Buffer (Sigma; 0.015%) were added               
to 1.2mL of alginate (Shadong Biotech; 0.3%) 
solution under constant stirring, followed by the 
addition of CaCl2 (Merck; 0.2mL) solution (0.1; 0.2; 
and 0.3%). RIP MJ-30 nanoparticles were formed 
spontaneously through poly-electrolyte complex 
(PEC). The nanoparticle suspension was then 
dialysed overnight at 4ᵒC.  
 
Characterization of alginate - RIP MJ-30 
nanoparticle 
Characteristic  of nanoparticles  were  
determined by measuring the entrapment efficiency 
(EE), particle size of nanoparticles using, poly-
dispersity index and zeta potential. Entrapment 
efficiency of RIP MJ-30 alginate nanoparticles was 
determined by measuring the un-reacted RIP MJ-C 
using BCA assay kit (Sigma Aldrich). Average 
particle size, polydispersity index (PI) and zeta 
potential of nanoparticles were determined using 
laser dynamic light scattering using DelsaTM Nano-
Submicron Particle Size and Zeta Potential 
Analyzer (Beckman Coulter).  
 
Bio-conjugation of RIP-MJ 30 nano par- ticles to 
Anti-EpCam antibody 
Nanoparticle suspension (625μL) was 
mixed with soulution of 0.1% EDAC (Sigma 
Aldrich; 190μL) using a vortex, followed by 
addition of anti-EpCam antibody (Abcam) solution 
(1750μL). MES Buffer (Merck) solution was then 
added to final volume of 5mL at three variants pH 
level: 4.5; 5.5; and 6.5. The mixture was then 
stirred (15min) followed by incubation (24h; 4ᵒC) 
and then dialysed overnight at 4°C. The conjugated 
formed were then analysed using Native-PAGE kit 
(Sigma Aldrich) and and BCA assay. Result of BCA 
assay was used to measure the Conjugation 
Efficiency with following equation: 
Conjugation efficiency (%) =   100% X 
A – B 
A 
A = Amount of total antibody; B = Amount of the 
free antibody 
 
Electrophoresis Native-PAGE system bio-
conjugation detection 
Conjugated nanoparticles (40µL) were 
mixed with loading TRIS buffer (10µL). 
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Electrophoresis was carried out in 1 x TBE buffer 
in polyacrylamide gel (8%), with the time of 6h. 
The visualization step was carried out with silver 
staining, then quantitative analysis for the band 
intensity was done by using the Image J-software.    
 
RESULTS AND DISCUSSION 
Alginate-RIP-MJ 30 nanoparticles  
The nanoparticles were formed through 
Polyelectrolyte Complex (PEC) method, where the 
negatively charged carboxylate groups of alginates 
(-COO-) formed numerous bonds with positively 
charged ammonium groups e(NH3+) in RIP MJ-30. 
In this nanoparticle formulation, Ca2+ from CaCl2 
cross-linked free carboxylate groups (-COO-) of 
alginates, encapsulating the RIP MJ-30 inside the 
polymer walls of alginate (Figure 1). 
Entrapment efficiency (EE) of each formula 
was determined through BCA assay (Table I). The 
statistical analysis do not show any significant 
different between the data values. However, it was 
revelaed that concentration of 0.2% CaCl2 resulted 
in nanoparticle with the highest percentage of EE 




Figure 1. Predicted nanoparticle polyelectrolyte 
complex (PEC) formation of RIP MJ-30, alginate, 
and calcium chloride 
 
The lower EE value in nanoparticle 
formulated with 0.1% CaCl2 is assumed due to the 
fact that there was not enough Ca2+ to form the 
nanoparticle entrapping RIP MJ-30. On the other 
hand, increasing the concentration of CaCl2 from 
0.2% to 0.3% unexpectedly caused a significant 
drop of EE value. It seemed that with 
concentration of 0.3%, an excess of Ca2+ might 
competes with RIP MJ-30 to bind with alginate, 
caused the lowering the amount of RIP MJ-30-
alginate complex.  








0.2 71.11  
0.3 47.97  
 
Characterization of Alginate - RIP MJ-30 
nanoparticle 
Particles obtained from the optimum 
formula of RIP MJ-30 alginate having size between 
187.4-218.60nm with an average of 153.7nm and 
zetta potential of -6.9mV. The polydispersity index 
(PI) of 0.279 showed that the nanoparticle system 
has a good uniformity in particle size.  Particle size 
is an important parameter in drug delivery system 
because they affect the loading capacity, drug 
release process, and stability of the nanoparticle 
(Fang et al., 2006). According to Gupta (2006) and 
Lu et al., (2009), nanoparticle with the size of 280 
nm or lower could be applied to deliver drugs 
through capillary blood vessel (Moharanj et al., 
2006; Gupta et al., 2006). Therefore, the resulted 
RIP MJ-30 alginate nanoparticle had an 
appropriate particle size to be developed as a 
targeted anti-cancer drug. 
 
Bio-conjugation of RIP-MJ 30 Nanoparticle to 
Anti-EpCam antibody 
Optimization of pH condition for the 
conjugation process was carried out in three pH 
variants: 4.5, 5.5, and 6.5 (the optimum pH 
medium range for EDAC reaction (Ranjan et al., 
2012). The optimum condition was firstly studied 
using free alginate to conjugate with Anti EpCAM 
antibody. Analysis was done using BCA reagent              
to detect the unconjugated antibody in the            
sample. The detected amount of free anti-EpCam 
antibody was then used to calculate the percentage 
value of conjugation efficiency using equation in 
section 2.3. The result of the conjugation reaction 
between the free alginate with anti-EpCAM             
(Table II). 
 








Efficiency  (%) 
4.5 43.5±8.74 56.49±8.78 
5.5 13.8±7.71 89.55±6.18 
6.5 32.5±5.97 67.45±6.02 
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The results indicated that out of the three 
samples, pH level of 5.5 showed the best value of 
conjugation efficiency, which was 89.55±6.18. 
Statistical analysis confirmed the significant 
differences between the data groups (t value 
<4.03, p<0.05, n=3).  
To confirm the result of the BCA assay, 
further analysis was done by using native-PAGE 
electrophoresis to separate and measure the un-
reacted antibody (Figure 2). The effectiveness of 
the conjugation reaction in every pH medium was 
then analyzed by comparing the protein band 
intensity using Image-J software. Result of intensity 
calculation (Table III), reveals that the pH level of 
5.5 is the best condition for the bioconjugation 
reaction.  Statistical analysis confirmed that there 
is significant differences between the data groups 
of efficiency (t value <4.03, p<0.05, n=3).  
The role of EDAC in the reaction is to form 
an active intermediate O-acylurea to react with 
amine groups in anti-EpCAM antibody, which was 
initiated by protonation of EDAC catalyst. Hence, 
an optimum pH was needed to facilitate the active 
intermediate to undergo the reaction. The result 
shown that conjugation at medium pH of 4.5 and 
6.5 resulting in low efficiency. This was suspected 
due to less protonation of the intermediate at pH 
of 6.5, while at pH 4.5 the protonation of amine 
groups occurred and caused lost of the amines 
reactivity.   
Based on the result, the conjugation 
reaction of RIP MJ-30 nanoparticle with anti Ep-
CAM was conducted at medium pH of 5.5. This 
conjugation resulting in the form of new 
nanoparticles with diameter size of 205.0nm. The 
diameter of new nanoparticles’ increased by 
46.7nm, from 153.7nm to 205.0nm. Since IgG 
antibodies are generally 20-40nm in length so the 
size of the conjugated nanoparticle should be 
173.7-193.7nm (Chen et al., 2004), lead to the 
supposition that nanoparticle of RIP MJ 30-anti 
EpCAM has been formed.  
 
CONCLUSION 
The optimum RIP MJ-30 nanoparticles was 
formulated using 0.3% alginate and 0.2% CaCl2. 
The RIP MJ-30 nanoparticle was then successfully 
conjugated to anti-EpCAM antibody on pH level 5.5 
 
 
Figure 2. Gel Electrophoresis native-PAGE samples in pH of 4.5 (A), 5.5 (B), 6.5 (C). D is control for 
antibody anti-EpCAM, E is control for sodium alginate 
 
Table III. Conjugation Efficiency measured Image-J software of Protein Band intensity form 
electrophoresis result 
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with conjugation efficiency of 89.55%, resulting in 
antibody anti-EpCam-conjugated nanoparticles 
with diameter of 205.0nm.  
 
ACKNOWLEDGEMENT 
We would like to thank DIKTI for the PUPT 
Grant(015/SP2H/LT/DRPM/II/2016) and the 
research team Dewa Ayu Arimurni and Wahyudi 
MDP for both technical and theore- tical assistance 
throughout the study. 
 
REFERENCES  
Barbieri L., Batelli MG., and Stirpe F. 1993. 
Ribosome-inactivating Proteins from plants. 
Biochim Biophys Acta 1154: 237-82. 
Chen Y., Cai J., Xu QC. and Chen ZW. 2004. Atomic 
force bio-analytics of po- lymerization and 
aggregation of phyco-erythrin-conjugated 
immunoglobulin G molecules. Mol Immunol 
41:1247-52. 
Ciptasari U., 2016, Skripsi. Conjugation Reaction        
of Anti-EpCAM Antibody on Nanoparticles 
of Base Fraction of Ribosome Inactivating 
Protein Mirabilis Jalapa L. (RIP MJ) Using 
EDAC as Catalyst, Yogyakarta; Faculty of 
Pharmacy, Universitas Gadjah Mada 
Fang C., Shi B., Pei YY., Hong MH., Wu J., Chen HZ. 
2006. In vivo tumor targeting of tumor 
necrosis factor-alpha-loaded stealth 
nanoparticles: effect of MePEG molecular 
weight and particle size. Eur J Pharm Sci 
27:27-36. 
Fujita M., Lee B., Khazenzon NM., Penichet ML., 
Wawrowsky KA., et al., 2007, Brain tumor 
tandem    targeting   using  a  combination of  
Gupta RB. 2006. Fundamentals of drug 
nanoparticles in nanoparticle technology for 
drug delivery. In Gupta RB and Kompella UB 
(Eds), Nanoparticle Technology for Drug 
Delivery (pp 1-9). New York, NY: Taylor & 
Francis Group. 
Hermanson TG. 1996. Bioconjugation Techniques. 
New York: Academic Press Inc. 3-4:169-70. 
Ikawati Z., Sudjadi, Sismindari. 2006. Cytotoxicity 
against Tumor Cell Lines of a Ribosome-
Inactivating Protein (RIP)-Like Protein 
Isolated from Leaves of Mirabilis jalapa L. 
Malays J Pharm Sci. 4:31–41. 
Ikhsan AN. 2017. Skripsi. Effect of Medium pH and 
Reactant Concentration on Conjugation 
Reaction Between Sodium Alginate and 
Antibody Anti-EpCAM catalyzed by EDAC. 
Yogyakarta; Faculty of Pharmacy, 
Universitas Gadjah Mada.  
Jin L., Hong Y., Pyo J., Song H., Kang JY., Lee SW., 
Yoon DS., Kim B., and No K. 2009. 
Monitoring of Swelling and Degrading 
Behavior of Alginate Beads using Optical 
Tweezers. Biochip Journal. 3: 213-8. 
Lu J., Liong M., Zink JI., Tamanoi F. 2007. 
Mesoporous silica nanoparticles as a 
delivery system for hydrophobic anticancer 
drugs. SMALL.; 3:1341–1346. 
Merril CR. 1990. Gel-staining techniques. In 
Deutscher MP (Ed) in Guide to Protein 
Purification. Methods Enzymol (182:477–
88). California: Academic press Inc.  
Mohanraj and Chen. 2006. Nanoparticles–a review. 
Trop J Pharm Res 5:561-73. 
monoclonal antibodies attached to 
biopoly(β-l-malic acid). J Control Release 
122:356-63 
Pertiwi D., Martien R., Sismindari and Ismail H. 
2018. Formulation of nanoparticles 
ribosome inactivating protein from Mirabilis 
jalapa L. (RIP MJ) conjugated with anti-
EpCAM antibody using low chain chitosan-
pectinand cytotoxcic acti-vity against breast 
cancer cell line. Pak. J. Pharm. Sci Vol 31(2), 
379 -384 
Ranjan AP., Mukerjee A., Helson L., Vishwanatha JK. 
2012. Scale up, op-timization and stability 
analysis of Curcumin C3 complex-loaded 
nanopar-ticles for cancer therapy. J Nano-
biotechnology 10:38. 
Saraei, Dougighi FM., Zolfagharian N., Bidhendi 
HM., Khaki S., and Inanlou P. 2013. Design 
and Evaluate Alginate Nanoparticle as A 
Protein Delivery System. Archives of Razi 
Institute. 68:139-46. 
Sismindari, Hartati MS., Adhyatmika. 2010. 
Cytotoxic selectivity of MJC0.3 and MJC0.5, 
acidic Ribosome-inactivating Proteins 
isolated from Mirabilis jalapa L. leaves 
against various cancer cell-lines, J Med Sci 
42:39 – 43. 
Stirpe F., and Batelli MG. 2006. Ribosome-
Inactivating Proteins: Progress and 
Problems. Cell Mol Life Sci 63:1850–66. 
Suryani F. 2016. Skripsi. Effect of Polyacrylamide 
Concentration and Developing Time on 
Electrophoresis Analysis for Nanoparticle 
RIP MJ-30 – BSA Conjugation. Yogyakarta; 
Faculty of Pharmacy, Universitas Gadjah 
Mada. 
Torchilin and Lukyanov. 2003. Peptide and  
protein drug delivery to and into tumors: 
Hilda Ismail 
Volume 30 Issue 1 (2019)  57 
challenges and solutions. Drug Discov Today 
15:259-66. 
Vanparijs N., Maji S., Louage B., Voorhaar L., 
Laplace D., et al. 2015. Polymer-protein 
conjugation via a “grafting to” approach: a 
comparative study of the performance of 
protein-reactive RAFT chain transfer agents. 
Polym Chem 6:5602–14. 
Wicaksono PA., Sismindari, Martien R., Ismail H. 
2016. Formulation and cytotoxicity of 
ribosome-inactivating protein Mirabilis 
jalapa L. nanoparticles using alginate-low 
viscosity chitosan conjugated with anti-
EpCAM antibodies in the T47D breast 
cancer cell line. Asian Pac J Cancer Prev 
17:2277-84. 
Wittig I. and Schägger H. 2005. Advantages and 
limitations of clear-native PAGE. Proteomics. 
5: 4338–46. 
 
 
 
 
